AUPH vs RJF · P/E 28, rev $160.9M vs rev $15.91B
Aurinia Pharmaceuticals Inc (AUPH) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
RJF (RJF) common stock.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. RJF currently screens at market cap $0.
Not investment advice. Open the AUPH and RJF stock pages for the full models.
Not investment advice.